The COPD Patient Management European Trial (COMET)
COMET
An International Phase IV Randomised Trial for Medical and Medico-economic Evaluations of Home-based Disease Management Program in Patients With Gold III/IV Chronic Obstructive Pulmonary Disease.
1 other identifier
interventional
346
4 countries
34
Brief Summary
The goal of the study is to evaluate a Home-Based Disease Management program specifically developed for patients with Gold III/IV COPD. By improving disease knowledge, awareness of significant clinical deterioration and self-management skills for patients, this Home-Based COPD Management Program is expected to reduce the severity of exacerbations, the need for emergency hospitalisations, thus demonstrating the efficacy and the cost effectiveness of this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 2010
Longer than P75 for phase_4
34 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 9, 2010
CompletedFirst Posted
Study publicly available on registry
November 16, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedJanuary 14, 2016
January 1, 2016
4.4 years
November 9, 2010
January 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of unscheduled hospital days
up to 12 months
Secondary Outcomes (6)
Number of hospital days due to severe COPD exacerbation
up to 12 months
Safety parameters
up to 12 months
Medico-economic data
up to 12 months
Health related quality of life
up to 12 months
Use of health care services
up to 12 months
- +1 more secondary outcomes
Study Arms (2)
Disease management program
EXPERIMENTALUsual site management
ACTIVE COMPARATORInterventions
* Individual, group and phone education sessions * Telephone supporter follow-up * LTOT monitoring
* Usual education as per site protocol * Usual follow-up as per site protocol * LTOT monitoring
Eligibility Criteria
You may qualify if:
- Confirmed Gold III/IV COPD
- Current or ex-smoker with a smoking history ≥ 10 pack-years
- At least one COPD exacerbation leading to hospitalization in the year before selection.
You may not qualify if:
- LTOT for another reason than COPD
- Severe concomitant disorder associated with a limited probability of survival (\< 6 months)
- Tracheostomy
- Long term oral corticosteroids therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Air Liquide Santé Internationallead
- ITEC Servicescollaborator
- Lincoln Medical and Mental Health Centercollaborator
Study Sites (34)
Centre Hospitalier d Antibes Juans-les-pins
Antibes, 06606, France
Hôpitaux Civils de Colmar - Hôpital Pasteur
Colmar, 68024, France
CHU de Grenoble
Grenoble, 38043, France
Centre Hospitalier du Mans
Le Mans, 72037, France
Hôpital de la Croix Rousse
Lyon, 69317, France
Assistance Publique Hôpitaux de Marseille - Hôpital Nord
Marseille, 13015, France
Hôpital MERCY
Metz, 57085, France
Hôpital Saint Louis
Paris, 75010, France
Groupe Hospitalier Pitié-Salpétrière
Paris, 75013, France
Groupe Hospitalier Saint Joseph
Paris, 75674, France
Hôpital Civil de Strasbourg
Strasbourg, 67098, France
Hôpital Beauregard - CHR METZ
Thionville, 57100, France
Hôpital Sainte Musse
Toulon, 83100, France
Marien Krankenhaus
Kassel, Hesse, 34001, Germany
Universitatklinikum
Aachen, 52074, Germany
Helios Hagen-Ambrock
Hagen, 58091, Germany
Thoraxklinik Heidelberg gGmbh
Heidelberg, 69126, Germany
Lungenklinik Hemer
Hemer, 58675, Germany
Fachkrankenhaus Kloster Grafschaft
Schmallenberg, 57392, Germany
Klinik für Pneumologie und Allergologie
Solingen, 42699, Germany
Universitätsklinikum Ulm, - Klinik Innere Medizin II
Ulm, 89081, Germany
Azienda ULSS 22 - Ospedale di Bussolengo
Bussolengo, 37012, Italy
ASL Viterbo
Civita Castellana, 01033, Italy
Ospedale di Macerata
Macerata, Italy
Azienda Ospedaliera, "Ospedale San Carlo Borromeo"
Milan, 20153, Italy
"Azienda Ospedaliera Niguarda
Milan, 20162, Italy
Azienda ospedialiera Di DESIO Vimercate
Seregno, 20831, Italy
Hospital La Princessa
Madrid, Madrid, 28006, Spain
Hospital Gregorio Maranon
Madrid, Madrid, 28007, Spain
Hospital Ramon Y Cajal
Madrid, Madrid, 28034, Spain
Hospital Universitario de Burgos
Burgos, 09006, Spain
Hospital San Pedro de Alcantara
Cáceres, 10001, Spain
Hospital Universitario de Asturia
Oviedo, 33006, Spain
Hospital Arnau de Vilanova
Valencia, 46015, Spain
Related Publications (2)
Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.
PMID: 34495549DERIVEDKessler R, Casan-Clara P, Koehler D, Tognella S, Viejo JL, Dal Negro RW, Diaz-Lobato S, Reissig K, Rodriguez Gonzalez-Moro JM, Devouassoux G, Chavaillon JM, Botrus P, Arnal JM, Ancochea J, Bergeron-Lafaurie A, De Abajo C, Randerath WJ, Bastian A, Cornelissen CG, Nilius G, Texereau JB, Bourbeau J. COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD. Eur Respir J. 2018 Jan 11;51(1):1701612. doi: 10.1183/13993003.01612-2017. Print 2018 Jan.
PMID: 29326333DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Romain KESSLER, MD
Hopital Civil de Strasbourg - France
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2010
First Posted
November 16, 2010
Study Start
September 1, 2010
Primary Completion
February 1, 2015
Study Completion
October 1, 2015
Last Updated
January 14, 2016
Record last verified: 2016-01